BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23:5644-5650. [PMID: 16110023 DOI: 10.1200/jco.2005.08.144] [Cited by in Crossref: 522] [Cited by in F6Publishing: 167] [Article Influence: 32.6] [Reference Citation Analysis]
Number Citing Articles
1 Oki E, Ando K, Kasagi Y, Zaitsu Y, Sugiyama M, Nakashima Y, Sonoda H, Ohgaki K, Saeki H, Maehara Y. Recent advances in multidisciplinary approach for rectal cancer. Int J Clin Oncol 2015;20:641-9. [PMID: 26100273 DOI: 10.1007/s10147-015-0858-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Ozden SA, Ozyurt H, Ozgen Z, Kilinc O, Oncel M, Gul AE, Karadayi N, Serakinci N, Kan B, Orun O. Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer. World J Gastroenterol 2011; 17(44): 4905-4910 [PMID: 22171132 DOI: 10.3748/wjg.v17.i44.4905] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
3 Liszka Ł, Zielińska-Pająk E, Pająk J, Gołka D, Starzewski J, Lorenc Z. Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy. World J Gastroenterol 2007; 13(4): 515-524 [DOI: 10.3748/wjg.v13.i4.515] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Hohenberger W, Lahmer G, Fietkau R, Croner RS, Merkel S, Göhl J, Sauer R. [Neoadjuvant radiochemotherapy for rectal cancer]. Chirurg 2009;80:294-302. [PMID: 19350306 DOI: 10.1007/s00104-009-1707-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Dodaro CA, Calogero A, Tammaro V, Pellegrino T, Lionetti R, Campanile S, Menkulazi M, Ciccozzi M, Iannicelli AM, Giallauria F, Sagnelli C. Colorectal Cancer in the Elderly Patient: The Role of Neo-adjuvant Therapy. Open Med (Wars) 2019;14:607-12. [PMID: 31428685 DOI: 10.1515/med-2019-0068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Asoglu O, Balik E, Kunduz E, Yamaner S, Akyuz A, Gulluoglu M, Kapran Y, Bugra D. Laparoscopic surgery for rectal cancer: outcomes in 513 patients. World J Surg 2013;37:883-92. [PMID: 23361097 DOI: 10.1007/s00268-013-1927-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
7 Skóra T, Nowak-Sadzikowska J, Martynów D, Wszołek M, Sas-Korczyńska B. Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors. J Radiat Oncol 2018;7:77-84. [PMID: 29576860 DOI: 10.1007/s13566-017-0340-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ostwal V, Kapoor A, Engineer R, Saklani A, deSouza A, Patil P, Arya S, Ankathi SK, Chopra S, Patil M, Jain S, Ramaswamy A. Systemic chemotherapy and short-course radiation in metastatic rectal cancers: A feasible paradigm in unresectable and potentially resectable cancers. South Asian J Cancer 2019;8:92-7. [PMID: 31069186 DOI: 10.4103/sajc.sajc_174_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Panagiotopoulou IG, Parashar D, Qasem E, Mezher-Sikafi R, Parmar J, Wells AD, Bajwa FM, Menon M, Jephcott CR. Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer: Does Time to Surgery Matter? Int Surg. 2015;100:968-973. [PMID: 26414816 DOI: 10.9738/intsurg-d-14-00192.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
10 Sung S, Son SH, Park EY, Kay CS. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy. PLoS One. 2017;12:e0173955. [PMID: 28291841 DOI: 10.1371/journal.pone.0173955] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
11 Gouvas N, Tsiaoussis J, Pechlivanides G, Zervakis N, Tzortzinis A, Avgerinos C, Dervenis C, Xynos E. Laparoscopic or open surgery for the cancer of the middle and lower rectum short-term outcomes of a comparative non-randomised study. Int J Colorectal Dis. 2009;24:761-769. [PMID: 19221764 DOI: 10.1007/s00384-009-0671-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
12 Liszka Ł, Zielińska-Pająk E, Pająk J, Gołka D, Starzewski J, Lorenc Z. Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy. World J Gastroenterol 2007; 13(4): 515-524 [PMID: 17278216 DOI: 10.3748/wjg.v13.i4.524] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Antelo G, Hierro C, Fernández JP, Baena E, Bugés C, Layos L, Manzano JL, Caro M, Mesia R. Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents. Drugs Context 2020;9:2020-2-4. [PMID: 32477420 DOI: 10.7573/dic.2020-2-4] [Reference Citation Analysis]
14 Ueberrueck T, Wurst C, Rauchfuß F, Knösel T, Settmacher U, Altendorf-Hofmann A. What factors influence 10-year survival after curative resection of a colorectal carcinoma? World J Surg 2013;37:2476-82. [PMID: 23838928 DOI: 10.1007/s00268-013-2138-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Cui J, Fang H, Zhang L, Wu YL, Zhang HZ. Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy. Chronic Dis Transl Med 2016;2:10-6. [PMID: 29063019 DOI: 10.1016/j.cdtm.2016.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Fung-Kee-Fung SD. Therapeutic approaches in the management of locally advanced rectal cancer. J Gastrointest Oncol 2014;5:353-61. [PMID: 25276408 DOI: 10.3978/j.issn.2078-6891.2014.067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Lim SB, Kim JC. Surgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy. J Korean Surg Soc 2013;84:1-8. [PMID: 23323229 DOI: 10.4174/jkss.2013.84.1.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Hathout L, Maloney-Patel N, Malhotra U, Wang SJ, Chokhavatia S, Dalal I, Poplin E, Jabbour SK. Management of locally advanced rectal cancer in the elderly: a critical review and algorithm. J Gastrointest Oncol 2018;9:363-76. [PMID: 29755777 DOI: 10.21037/jgo.2017.10.10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
19 Lee HS, Choi DH, Park HC, Park W, Yu JI, Chung K. Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer. Radiat Oncol J 2016;34:186-92. [PMID: 27592514 DOI: 10.3857/roj.2016.01746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 McGee SF, AlGhareeb W, Ahmad CH, Armstrong D, Babak S, Berry S, Biagi J, Booth C, Bossé D, Champion P, Colwell B, Finn N, Goel R, Gray S, Green J, Harb M, Hyde A, Jeyakumar A, Jonker D, Kanagaratnam S, Kavan P, MacMillan A, Muinuddin A, Patil N, Porter G, Powell E, Ramjeesingh R, Raza M, Rorke S, Seal M, Servidio-Italiano F, Siddiqui J, Simms J, Smithson L, Snow S, St-Hilaire E, Stuckless T, Tate A, Tehfe M, Thirlwell M, Tsvetkova E, Valdes M, Vickers M, Virik K, Welch S, Marginean C, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference 2017. Curr Oncol 2018;25:262-74. [PMID: 30111967 DOI: 10.3747/co.25.4083] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Nagasaki T, Akiyoshi T, Fujimoto Y, Konishi T, Nagayama S, Fukunaga Y, Ueno M. Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases. World J Surg. 2017;41:876-883. [PMID: 27730348 DOI: 10.1007/s00268-016-3748-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
22 Yaffee P, Osipov A, Tan C, Tuli R, Hendifar A. Review of systemic therapies for locally advanced and metastatic rectal cancer. J Gastrointest Oncol. 2015;6:185-200. [PMID: 25830038 DOI: 10.3978/j.issn.2078-6891.2014.112] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
23 Jwa E, Kim JH, Han S, Park JH, Lim SB, Kim JC, Hong YS, Kim TW, Yu CS. Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer. Br J Cancer. 2014;111:249-254. [PMID: 24967873 DOI: 10.1038/bjc.2014.256] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
24 Wong JSM, Tan GHC, Chia CS, Ong CAJ, Teo MCC. Management of synchronous lateral pelvic nodal metastasis in rectal cancer in the era of neoadjuvant chemoradiation: A systemic review. World J Gastrointest Surg 2020; 12(5): 247-258 [PMID: 32551030 DOI: 10.4240/wjgs.v12.i5.247] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Liersch T, Rothe H, Ghadimi BM, Becker H. [Individualizing treatment for locally advanced rectal cancer]. Chirurg 2009;80:281-93. [PMID: 19350305 DOI: 10.1007/s00104-008-1617-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
26 Käser SA, Froelicher J, Li Q, Müller S, Metzger U, Castiglione M, Laffer UT, Maurer CA. Adenocarcinomas of the upper third of the rectum and the rectosigmoid junction seem to have similar prognosis as colon cancers even without radiotherapy, SAKK 40/87. Langenbecks Arch Surg 2015;400:675-82. [PMID: 25163656 DOI: 10.1007/s00423-014-1243-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
27 Tanis PJ, Doeksen A, van Lanschot JJ. Intentionally curative treatment of locally recurrent rectal cancer: a systematic review. Can J Surg. 2013;56:135-144. [PMID: 23517634 DOI: 10.1503/cjs.025911] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
28 Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O'Callaghan C, Myint AS, Bessell E, Thompson LC, Parmar M, Stephens RJ, Sebag-Montefiore D; MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828. [PMID: 19269520 DOI: 10.1016/s0140-6736(09)60485-2] [Cited by in Crossref: 651] [Cited by in F6Publishing: 197] [Article Influence: 54.3] [Reference Citation Analysis]
29 Marks JH, Montenegro GA, Salem JF, Shields MV, Marks GJ. Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer. Tech Coloproctol. 2016;20:467-473. [PMID: 27178183 DOI: 10.1007/s10151-016-1482-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
30 Peng HH, Zhou XH, Zhou TC, Qiu XS, You KY. Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery. Radiat Oncol 2019;14:8. [PMID: 30651116 DOI: 10.1186/s13014-019-1206-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Moslim MA, Bastawrous AL, Jeyarajah DR. Neoadjuvant Pelvic Radiotherapy in the Management of Rectal Cancer with Synchronous Liver Metastases: Is It Worth It? J Gastrointest Surg 2021. [PMID: 34100244 DOI: 10.1007/s11605-021-05042-w] [Reference Citation Analysis]
32 Wang X, Zheng B, Lu X, Bai R, Feng L, Wang Q, Zhao Y, He S. Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data. PLoS One 2018;13:e0200142. [PMID: 30001375 DOI: 10.1371/journal.pone.0200142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
33 Romesser PB, Wu AJ, Cercek A, Smith JJ, Weiser M, Saltz L, Garcia-Aguilar J, Crane CH. Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center. Adv Radiat Oncol. 2020;. [PMID: 32322758 DOI: 10.1016/j.adro.2020.04.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
34 Kilsdonk MJ, van Dijk BA, Otter R, Siesling S, van Harten WH. The impact of organisational external peer review on colorectal cancer treatment and survival in the Netherlands. Br J Cancer 2014;110:850-8. [PMID: 24423922 DOI: 10.1038/bjc.2013.814] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
35 Tominaga T, Akiyoshi T, Yamamoto N, Taguchi S, Mori S, Nagasaki T, Fukunaga Y, Ueno M. Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One 2019;14:e0212978. [PMID: 30807610 DOI: 10.1371/journal.pone.0212978] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
36 Bisceglia G, Mastrodonato N, Tardio B, Mazzoccoli G, Corsa P, Troiano M, Parisi S. Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial. Oncotarget 2014;5:11143-53. [PMID: 25373926 DOI: 10.18632/oncotarget.2603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Häfner MF, Debus J. Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives. Visc Med 2016;32:172-7. [PMID: 27493944 DOI: 10.1159/000446486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
38 Wu XY, Wu ZF, Cao QH, Chen C, Chen ZW, Xu Z, Li WS, Liu FK, Yao XQ, Li G. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy. World J Gastroenterol 2014; 20(43): 16268-16274 [PMID: 25473182 DOI: 10.3748/wjg.v20.i43.16268] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
39 Murimwa G, Hester C, Mansour JC, Polanco PM, Porembka MR, Wang SC, Zeh HJ Jr, Yopp AC. Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database. J Gastrointest Surg 2021;25:1815-27. [PMID: 32705618 DOI: 10.1007/s11605-020-04729-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Guimas V, Boustani J, Schipman B, Lescut N, Puyraveau M, Bosset JF, Servagi-Vernat S. Preoperative Chemoradiotherapy for Rectal Cancer in Patients Aged 75 Years and Older: Acute Toxicity, Compliance with Treatment, and Early Results. Drugs Aging 2016;33:419-25. [PMID: 27138958 DOI: 10.1007/s40266-016-0367-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
41 Miwa K, Oki E, Enomoto M, Ihara K, Ando K, Fujita F, Tominaga M, Mori S, Nakayama G, Shimokawa M, Saeki H, Baba H, Mori M, Akagi Y. Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301). BMC Cancer 2021;21:23. [PMID: 33402130 DOI: 10.1186/s12885-020-07766-5] [Reference Citation Analysis]
42 Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O'Callaghan C, Myint AS, Bessell E, Thompson LC. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828. [PMID: 19269520 DOI: 10.1016/S0140-6736(09) 60485-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Taniguchi CM, Miao YR, Diep AN, Wu C, Rankin EB, Atwood TF, Xing L, Giaccia AJ. PHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2. Sci Transl Med 2014;6:236ra64. [PMID: 24828078 DOI: 10.1126/scitranslmed.3008523] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 12.0] [Reference Citation Analysis]
44 van Eeghen EE, den Boer F, Bakker SD, Loffeld RJ. Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study. J Gastrointest Oncol 2016;7:321-5. [PMID: 27284462 DOI: 10.21037/jgo.2015.10.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
45 Tominaga T, Nagasaki T, Akiyoshi T, Fukunaga Y, Fujimoto Y, Yamaguchi T, Konishi T, Nagayama S, Ueno M. Feasibility of neoadjuvant therapy for elderly patients with locally advanced rectal cancer. Surg Today 2019;49:694-703. [PMID: 30937632 DOI: 10.1007/s00595-019-01801-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Lavan NA, Kavanagh DO, Martin J, Small C, Joyce MR, Faul CM, Kelly PJ, O'Riordain M, Gillham CM, Armstrong JG, Salib O, McNamara DA, McVey G, O'Neill BD. The curative management of synchronous rectal and prostate cancer. Br J Radiol 2016;89:20150292. [PMID: 26539631 DOI: 10.1259/bjr.20150292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
47 Glimelius B. Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future. Ups J Med Sci 2012;117:225-36. [PMID: 22512246 DOI: 10.3109/03009734.2012.658974] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
48 Kim IK, Lim BJ, Kang J, Kim SA, Kang D, Sohn SK, Lee KY. Clinical impact of fat clearing technique in nodal staging of rectal cancer after preoperative chemoradiotherapy. J Korean Surg Soc 2013;85:30-4. [PMID: 23833758 DOI: 10.4174/jkss.2013.85.1.30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
49 Shin JS, Tut TG, Yang T, Lee CS. Radiotherapy response in microsatellite instability related rectal cancer. Korean J Pathol 2013;47:1-8. [PMID: 23482947 DOI: 10.4132/KoreanJPathol.2013.47.1.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
50 Cai G, Xu Y, Zhu J, Gu WL, Zhang S, Ma XJ, Cai SJ, Zhang Z. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation. World J Gastroenterol 2013; 19(33): 5520-5527 [PMID: 24023496 DOI: 10.3748/wjg.v19.i33.5520] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
51 Zitt M, DeVries A, Thaler J, Kafka-Ritsch R, Eisterer W, Lukas P, Öfner D. Long-term surveillance of locally advanced rectal cancer patients with neoadjuvant chemoradiation and aggressive surgical treatment of recurrent disease: a consecutive single-centre experience. Int J Colorectal Dis. 2015;30:1705-1714. [PMID: 26293791 DOI: 10.1007/s00384-015-2366-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Sorrentino L, Guaglio M, Battaglia L, Bonfanti G, Vitellaro M, Bianchi AC, Milione M, Belli F. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study. Int J Colorectal Dis 2019;34:2161-9. [PMID: 31741026 DOI: 10.1007/s00384-019-03446-4] [Reference Citation Analysis]
53 Kitz J, Fokas E, Beissbarth T, Ströbel P, Wittekind C, Hartmann A, Rüschoff J, Papadopoulos T, Rösler E, Ortloff-Kittredge P, Kania U, Schlitt H, Link KH, Bechstein W, Raab HR, Staib L, Germer CT, Liersch T, Sauer R, Rödel C, Ghadimi M, Hohenberger W; German Rectal Cancer Study Group. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. JAMA Surg 2018;153:e181607. [PMID: 29874375 DOI: 10.1001/jamasurg.2018.1607] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 15.3] [Reference Citation Analysis]
54 Guckenberger M, Wulf J, Thalheimer A, Wehner D, Thiede A, Müller G, Sailer M, Flentje M. Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results. Radiat Oncol 2009;4:67. [PMID: 20025752 DOI: 10.1186/1748-717X-4-67] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
55 Abraha I, Aristei C, Palumbo I, Lupattelli M, Trastulli S, Cirocchi R, De Florio R, Valentini V. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. Cochrane Database Syst Rev. 2018;10:CD002102. [PMID: 30284239 DOI: 10.1002/14651858.cd002102.pub3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
56 Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol 2017;8:990-7. [PMID: 29299359 DOI: 10.21037/jgo.2017.09.02] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
57 Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065. [PMID: 27189416 DOI: 10.1038/nrdp.2015.65] [Cited by in Crossref: 485] [Cited by in F6Publishing: 484] [Article Influence: 80.8] [Reference Citation Analysis]
58 Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-820. [PMID: 19269519 DOI: 10.1016/s0140-6736(09)60484-0] [Cited by in Crossref: 969] [Cited by in F6Publishing: 316] [Article Influence: 80.8] [Reference Citation Analysis]
59 Osti MF, Agolli L, Bracci S, Masoni L, Valeriani M, Falco T, De Sanctis V, Maurizi Enrici R. Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients. Int J Colorectal Dis. 2014;29:835-842. [PMID: 24825722 DOI: 10.1007/s00384-014-1879-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
60 Suppiah A, Hartley JE, Monson JR. Advances in radiotherapy in operable rectal cancer. Dig Surg 2009;26:187-99. [PMID: 19494494 DOI: 10.1159/000219931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
61 Aisu Y, Kato S, Kadokawa Y, Yasukawa D, Kimura Y, Takamatsu Y, Kitano T, Hori T. Feasibility of Extended Dissection of Lateral Pelvic Lymph Nodes During Laparoscopic Total Mesorectal Excision in Patients with Locally Advanced Lower Rectal Cancer: A Single-Center Pilot Study After Neoadjuvant Chemotherapy. Med Sci Monit. 2018;24:3966-3977. [PMID: 29890514 DOI: 10.12659/msm.909163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Muñoz-Galván S, Rivero M, Peinado-Serrano J, Martinez-Pérez J, Fernández-Fernández MC, Ortiz MJ, García-Heredia JM, Carnero A. PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208. Cells 2020;9:E1071. [PMID: 32344898 DOI: 10.3390/cells9051071] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Jeong DH, Lee HB, Hur H, Min BS, Baik SH, Kim NK. Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Korean Surg Soc 2013;84:338-45. [PMID: 23741691 DOI: 10.4174/jkss.2013.84.6.338] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
64 Ulrich A, Weitz J, Büchler MW. [Rectal cancer. How much radiotherapy do surgery patients need?]. Chirurg 2009;80:266-73. [PMID: 19271158 DOI: 10.1007/s00104-008-1618-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
65 Deshpande SS, Donneys A, Farberg AS, Tchanque-Fossuo CN, Felice PA, Buchman SR. Quantification and characterization of radiation-induced changes to mandibular vascularity using micro-computed tomography. Ann Plast Surg 2014;72:100-3. [PMID: 23314188 DOI: 10.1097/SAP.0b013e318255a57d] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
66 Okuno K, Aoyama T, Oba K, Yokoyama N, Matsuhashi N, Kunieda K, Nishimura Y, Akamatsu H, Kobatake T, Morita S, Yoshikawa T, Sakamoto J, Saji S. Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial). Cancer Chemother Pharmacol 2018;81:65-71. [PMID: 29094178 DOI: 10.1007/s00280-017-3466-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
67 Glimelius B. Neo-adjuvant radiotherapy in rectal cancer. World J Gastroenterol 2013; 19(46): 8489-8501 [PMID: 24379566 DOI: 10.3748/wjg.v19.i46.8489] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
68 Yorio JT, Bhadkamkar NA, Kee BK, Garrett CR. A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas. Int J Surg Oncol 2012;2012:863034. [PMID: 22666572 DOI: 10.1155/2012/863034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Holm M, Joenväärä S, Saraswat M, Tohmola T, Ristimäki A, Renkonen R, Haglund C. Preoperative Radiotherapy Leads to Significant Differences in the Plasma Protein Profile of Rectal Cancer Patients. Oncology 2020;98:493-500. [PMID: 32294655 DOI: 10.1159/000505697] [Reference Citation Analysis]
70 Gevaert T, Engels B, Garibaldi C, Verellen D, Deconinck P, Duchateau M, Reynders T, Tournel K, De Ridder M. Implementation of HybridArc treatment technique in preoperative radiotherapy of rectal cancer: dose patterns in target lesions and organs at risk as compared to helical Tomotherapy and RapidArc. Radiat Oncol 2012;7:120. [PMID: 22849723 DOI: 10.1186/1748-717X-7-120] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
71 Das P, Crane CH. Staging, prognostic factors, and therapy of localized rectal cancer. Curr Oncol Rep 2009;11:167-74. [PMID: 19336008 DOI: 10.1007/s11912-009-0025-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
72 Lee SW, Lee JH, Lee IK, Oh ST, Kim DY, Kim TH, Oh JH, Baek JY, Chang HJ, Park HC, Kim HC, Chie EK, Nam TK, Jang HS. The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma. Cancer Res Treat 2018;50:1039-50. [PMID: 29161802 DOI: 10.4143/crt.2017.252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Zhang S, Chen F, Ma X, Wang M, Yu G, Shen F, Gao X, Lu J. MRI-based nomogram analysis: recognition of anterior peritoneal reflection and its relationship to rectal cancers. BMC Med Imaging 2021;21:50. [PMID: 33731051 DOI: 10.1186/s12880-021-00583-7] [Reference Citation Analysis]
74 Kim WR, Han YD, Cho MS, Hur H, Min BS, Lee KY, Kim NK. Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer. Medicine94:e1133. [PMID: 26181550 DOI: 10.1097/md.0000000000001133] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
75 Jones WE 3rd, Thomas CR Jr, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, Das P, Goodman KA, Hong TS, Jabbour SK, Konski AA, Koong AC, Rodriguez-Bigas M, Small W Jr, Zook J, Suh WW. ACR appropriateness criteria®  resectable rectal cancer. Radiat Oncol 2012;7:161. [PMID: 23006527 DOI: 10.1186/1748-717X-7-161] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
76 Chen CH, Hsieh MC, Hsiao PK, Lin EK, Lu YJ, Wu SY. A critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinoma. J Cancer 2017;8:1927-34. [PMID: 28819391 DOI: 10.7150/jca.17930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
77 Jäger T, Neureiter D, Fallaha M, Schredl P, Kiesslich T, Urbas R, Klieser E, Holzinger J, Sedlmayer F, Emmanuel K, Dinnewitzer A. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. Strahlenther Onkol 2018;194:991-1006. [PMID: 30069738 DOI: 10.1007/s00066-018-1340-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
78 Beppu N, Yoshie H, Kimura F, Aihara T, Doi H, Kamikonya N, Matsubara N, Tomita N, Yanagi H, Yamanaka N. Clinicopathological outcomes of preoperative chemoradiotherapy using S-1 plus Irinotecan for T4 lower rectal cancer. Surg Today 2016;46:852-9. [PMID: 26363781 DOI: 10.1007/s00595-015-1250-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
79 Tseng M, Soon YY, Vellayappan B, Ho F, Tey J. Radiation therapy for rectal cancer. J Gastrointest Oncol 2019;10:1238-50. [PMID: 31949945 DOI: 10.21037/jgo.2018.12.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Dewdney A, Cunningham D, Chau I. Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies. Oncologist. 2013;18:833-842. [PMID: 23821325 DOI: 10.1634/theoncologist.2013-0022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
81 Park SY, Lee SJ, Cho HJ, Kim JT, Yoon HR, Lee KH, Kim BY, Lee Y, Lee HG. Epsilon-Globin HBE1 Enhances Radiotherapy Resistance by Down-Regulating BCL11A in Colorectal Cancer Cells. Cancers (Basel) 2019;11:E498. [PMID: 30965648 DOI: 10.3390/cancers11040498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
82 Kaytan-Saglam E, Balik E, Saglam S, Akgün Z, Ibis K, Keskin M, Dagoglu N, Kapran Y, Gulluoglu M. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer. J Cancer Res Clin Oncol 2017;143:1597-603. [PMID: 28374169 DOI: 10.1007/s00432-017-2406-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
83 Wu JX, Wang Y, Chen N, Chen LC, Bai PG, Pan JJ. In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer. Radiat Oncol 2014;9:159. [PMID: 25052511 DOI: 10.1186/1748-717X-9-159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
84 Pham TT, Liney G, Wong K, Henderson C, Rai R, Graham PL, Borok N, Truong MX, Lee M, Shin JS, Hudson M, Barton MB. Multi-parametric magnetic resonance imaging assessment of whole tumour heterogeneity for chemoradiotherapy response prediction in rectal cancer. Phys Imaging Radiat Oncol 2021;18:26-33. [PMID: 34258404 DOI: 10.1016/j.phro.2021.03.003] [Reference Citation Analysis]
85 Pechlivanides G, Gourtsoyianni S, Gouvas N, Sougklakos J, Xynos E. Management of the adenocarcinoma of the upper rectum: a reappraisal. Updates Surg 2021;73:513-26. [PMID: 33108641 DOI: 10.1007/s13304-020-00903-6] [Reference Citation Analysis]
86 Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008;71:1175-1180. [PMID: 18207667 DOI: 10.1016/j.ijrobp.2007.11.018] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
87 Perrakis A, Weber K, Merkel S, Matzel K, Agaimy A, Gebbert C, Hohenberger W. Lymph node metastasis of carcinomas of transverse colon including flexures. Consideration of the extramesocolic lymph node stations. Int J Colorectal Dis. 2014;29:1223-1229. [PMID: 25060216 DOI: 10.1007/s00384-014-1971-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
88 Birkman EM, Elzagheid A, Jokilehto T, Avoranta T, Korkeila E, Kulmala J, Syrjänen K, Westermarck J, Sundström J. Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer. Cancer Med 2018;7:698-706. [PMID: 29441695 DOI: 10.1002/cam4.1361] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
89 Akgun E, Ozkok S, Tekin M, Yoldas T, Caliskan C, Kose T, Karabulut B, Sezak M, Elmas N, Ozutemiz O. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. World J Surg Oncol 2017;15:205. [PMID: 29166925 DOI: 10.1186/s12957-017-1275-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
90 Wolf EA, Malatek DL. Locally advanced rectal cancer: does assessment of response after neoadjuvant chemoradiotherapy impact management? J Adv Pract Oncol 2013;4:438-44. [PMID: 25032024 DOI: 10.6004/jadpro.2013.4.6.9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
91 Rana N, Chakravarthy AB, Kachnic LA. Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design. Curr Treat Options Oncol. 2017;18:13. [PMID: 28281215 DOI: 10.1007/s11864-017-0454-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
92 Jin F, Luo H, Zhou J, Wu Y, Sun H, Liu H, Zheng X, Wang Y. Dose-time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer. Ther Adv Med Oncol 2020;12:1758835920907537. [PMID: 32165928 DOI: 10.1177/1758835920907537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
93 Sung S, Son SH, Kay CS, Lee YS. Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy. Medicine (Baltimore) 2016;95:e2965. [PMID: 26962798 DOI: 10.1097/MD.0000000000002965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
94 Ho V, Chung L, Singh A, Lea V, Revoltar M, Lim SH, Tut TG, Ng W, Lee M, de Souza P, Shin JS, Soon Lee C. Early Postoperative Low Expression of RAD50 in Rectal Cancer Patients Associates with Disease-Free Survival. Cancers (Basel) 2017;9:E163. [PMID: 29189711 DOI: 10.3390/cancers9120163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
95 Rivero M, Peinado-Serrano J, Muñoz-Galvan S, Espinosa-Sánchez A, Suarez-Martinez E, Felipe-Abrio B, Fernández-Fernández MC, Ortiz MJ, Carnero A. MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy. Oncotarget 2018;9:32958-71. [PMID: 30250642 DOI: 10.18632/oncotarget.26010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
96 Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 2020;5:567-72. [PMID: 32775771 DOI: 10.1016/j.adro.2020.04.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
97 Biondi A, Vacante M, Ambrosino I, Cristaldi E, Pietrapertosa G, Basile F. Role of surgery for colorectal cancer in the elderly. World J Gastrointest Surg 2016; 8(9): 606-613 [PMID: 27721923 DOI: 10.4240/wjgs.v8.i9.606] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
98 Chen W, Li Q, Fan Y, Li D, Jiang L, Qiu P, Tang L. Factors Predicting Difficulty of Laparoscopic Low Anterior Resection for Rectal Cancer with Total Mesorectal Excision and Double Stapling Technique. PLoS One 2016;11:e0151773. [PMID: 26992004 DOI: 10.1371/journal.pone.0151773] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
99 Tokuhara K, Ueyama Y, Nakatani K, Yoshioka K, Kon M. Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients. World J Surg Oncol 2016;14:136. [PMID: 27129578 DOI: 10.1186/s12957-016-0898-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
100 Habr-Gama A, São Julião GP, Mattacheo A, de Campos-Lobato LF, Aleman E, Vailati BB, Gama-Rodrigues J, Perez RO. Extralevator Abdominal Perineal Excision Versus Standard Abdominal Perineal Excision: Impact on Quality of the Resected Specimen and Postoperative Morbidity. World J Surg 2017;41:2160-7. [PMID: 28265736 DOI: 10.1007/s00268-017-3963-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
101 Kong X, Li J, Cai Y, Tian Y, Chi S, Tong D, Hu Y, Yang Q, Poston G, Yuan Y, Ding K. A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database. BMC Cancer. 2018;18:50. [PMID: 29310604 DOI: 10.1186/s12885-017-3796-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
102 Krishnamurthi SS, Seo Y, Kinsella TJ. Adjuvant therapy for rectal cancer. Clin Colon Rectal Surg 2007;20:167-81. [PMID: 20011198 DOI: 10.1055/s-2007-984861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
103 Khan SM, Emile SH, Barsom SH, Ahsan SO. Development of the 'PREDICT' score through a systematic review and meta-analysis of the predictive parameters for locoregional recurrence after total mesorectal excision. Updates Surg 2021;73:35-46. [PMID: 32734579 DOI: 10.1007/s13304-020-00853-z] [Reference Citation Analysis]
104 Orsini RG, Wiggers T, DeRuiter MC, Quirke P, Beets-Tan RG, van de Velde CJ, Rutten HJ. The modern anatomical surgical approach to localised rectal cancer. EJC Suppl 2013;11:60-71. [PMID: 26217114 DOI: 10.1016/j.ejcsup.2013.07.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
105 Dewdney A, Cunningham D. Toward the non-surgical management of locally advanced rectal cancer. Curr Oncol Rep 2012;14:267-76. [PMID: 22460631 DOI: 10.1007/s11912-012-0234-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
106 Siegel R, Cuesta MA, Targarona E, Bader FG, Morino M, Corcelles R, Lacy AM, Påhlman L, Haglind E, Bujko K, Bruch HP, Heiss MM, Eikermann M, Neugebauer EA; European Association for Endoscopic Surgery (EAES). Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2011;25:2423-40. [PMID: 21701921 DOI: 10.1007/s00464-011-1805-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
107 Fu XL, Fang Z, Shu LH, Tao GQ, Wang JQ, Rui ZL, Zhang YJ, Tian ZQ. Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer. Oncotarget 2017;8:34340-51. [PMID: 28423720 DOI: 10.18632/oncotarget.16127] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
108 Marijnen CAM, Peters FP, Rödel C, Bujko K, Haustermans K, Fokas E, Glynne-Jones R, Valentini V, Spindler KG, Guren MG, Maingon P, Calvo FA, Pares O, Glimelius B, Sebag-Montefiore D. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. Radiother Oncol 2020;148:213-5. [PMID: 32342861 DOI: 10.1016/j.radonc.2020.03.039] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 36.0] [Reference Citation Analysis]
109 Xynos E, Tekkis P, Gouvas N, Vini L, Chrysou E, Tzardi M, Vassiliou V, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A, Christodoulou C, Dervenis C, Emmanouilidis C, Georgiou P, Katopodi O, Kountourakis P, Makatsoris T, Papakostas P, Papamichael D, Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Triantopoulou C, Xynogalos S, Karachaliou N, Ziras N, Zoras O, Souglakos J; [the Executive Team on behalf of the Hellenic Society of Medical Oncologists (HeSMO)]. Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol 2016;29:103-26. [PMID: 27064746 DOI: 10.20524/aog.2016.0003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
110 Kleiman LB, Krebs AM, Kim SY, Hong TS, Haigis KM. Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers. PLoS One 2013;8:e82982. [PMID: 24349411 DOI: 10.1371/journal.pone.0082982] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
111 Treder M, Vogelsang RP, Janssen S, Schild SE, Holländer NH, Rades D. Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer. In Vivo 2018;32:1481-4. [PMID: 30348705 DOI: 10.21873/invivo.11403] [Reference Citation Analysis]
112 Wolf M, Zehentmayr F, Belka C. [Radiotherapy of rectal cancer]. Radiologe 2012;52:545-9. [PMID: 22618627 DOI: 10.1007/s00117-011-2286-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
113 Hu X, Li YQ, Li QG, Ma YL, Peng JJ, Cai SJ. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis. Oncologist 2019;24:803-11. [PMID: 29674444 DOI: 10.1634/theoncologist.2017-0600] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
114 Ho V, Chung L, Revoltar M, Lim SH, Tut TG, Abubakar A, Henderson CJ, Chua W, Ng W, Lee M, De Souza P, Morgan M, Lee CS, Shin JS. MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response. PLoS One 2016;11:e0167675. [PMID: 27930716 DOI: 10.1371/journal.pone.0167675] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
115 Sterzing F, Hoehle F, Ulrich A, Jensen A, Debus J, Muenter M. Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients. J Radiat Res 2015;56:169-76. [PMID: 25341424 DOI: 10.1093/jrr/rru089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
116 Kim MB, Hong TS, Wo JY. Treatment of stage II-III rectal cancer patients. Curr Oncol Rep 2014;16:362. [PMID: 24323626 DOI: 10.1007/s11912-013-0362-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
117 Althumairi AA, Gearhart SL. Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond. J Gastrointest Oncol. 2015;6:296-306. [PMID: 26029457 DOI: 10.3978/j.issn.2078-6891.2015.022] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
118 Eismann N, Emmermann A, Zornig C. [Individualization of guidelines. Approach for rectal cancer in UICC stages II and III]. Chirurg 2014;85:125-30. [PMID: 23861172 DOI: 10.1007/s00104-013-2551-7] [Reference Citation Analysis]
119 Voboril R, Voborilova J, Rychterova V, Jirasek T, Dvorak J. Dissociated invasively growing cancer cells with NF-kappaB/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data. Clin Exp Metastasis. 2008;25:491-496. [PMID: 18324356 DOI: 10.1007/s10585-008-9155-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
120 Aghili M, Khalili N, Khalili N, Babaei M, Farhan F, Haddad P, Salarvand S, Keshvari A, Fazeli MS, Mohammadi N, Ghalehtaki R. Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial. Radiat Oncol J 2020;38:119-28. [PMID: 33012155 DOI: 10.3857/roj.2020.00115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Peng HH, Liao ZW, Lin XD, Qiu XS, You KY. Definitive radiotherapy or chemoradiotherapy for distal rectal cancer with early stage of cT1-2N0. Cancer Manag Res 2019;11:5221-9. [PMID: 31354342 DOI: 10.2147/CMAR.S198113] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Li J, Liu Y, Wang JW, Gao Y, Hu YT, He JJ, Yu XY, Hu HG, Yuan Y, Zhang SZ, Ding KF. Oxaliplatin-based adjuvant chemotherapy without radiotherapy can improve the survival of locally-advanced rectal cancer. PLoS One 2014;9:e107872. [PMID: 25243406 DOI: 10.1371/journal.pone.0107872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, van den Brule AJ, van den Berg HA, Rutten HJ. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.Ann Surg Oncol. 2008;15:1937-1947. [PMID: 18389321 DOI: 10.1245/s10434-008-9896-z] [Cited by in Crossref: 133] [Cited by in F6Publishing: 94] [Article Influence: 10.2] [Reference Citation Analysis]
124 Ishihara S, Watanabe T, Kiyomatsu T, Yasuda K, Nagawa H. Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer. Int J Colorectal Dis 2010;25:1417-25. [PMID: 20809426 DOI: 10.1007/s00384-010-1051-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
125 Kim DD, Eng C. The current state of targeted agents in rectal cancer. Int J Surg Oncol 2012;2012:406830. [PMID: 22675625 DOI: 10.1155/2012/406830] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
126 Gao XH, Zhai BZ, Li J, Kabemba JLT, Gong HF, Bai CG, Liu ML, Zhang ST, Shen F, Liu LJ, Zhang W. Which Definition of Upper Rectal Cancer Is Optimal in Selecting Stage II or III Rectal Cancer Patients to Avoid Postoperative Adjuvant Radiation? Front Oncol 2020;10:625459. [PMID: 33643920 DOI: 10.3389/fonc.2020.625459] [Reference Citation Analysis]
127 Mitin T, Enestvedt CK, Thomas CR Jr. Management of oligometastatic rectal cancer: is liver first? J Gastrointest Oncol 2015;6:201-7. [PMID: 25830039 DOI: 10.3978/j.issn.2078-6891.2014.086] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
128 Corrò C, Dutoit V, Koessler T. Emerging Trends for Radio-Immunotherapy in Rectal Cancer. Cancers (Basel) 2021;13:1374. [PMID: 33803620 DOI: 10.3390/cancers13061374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Song C, Song S, Kim JS, Oh HK, Kim DW, Lee KW, Kim JH, Eom KY, Kim IA, Kang SB. Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis. PLoS One 2015;10:e0123657. [PMID: 25902069 DOI: 10.1371/journal.pone.0123657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
130 Puglisi C, Giuffrida R, Borzì G, Di Mattia P, Costa A, Colarossi C, Deiana E, Picardo MC, Colarossi L, Mare M, Marino L, Di Grazia A, Forte S. Radiosensitivity of Cancer Stem Cells Has Potential Predictive Value for Individual Responses to Radiotherapy in Locally Advanced Rectal Cancer. Cancers (Basel) 2020;12:E3672. [PMID: 33297488 DOI: 10.3390/cancers12123672] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Freischlag K, Sun Z, Adam MA, Kim J, Palta M, Czito BG, Migaly J, Mantyh CR. Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer. JAMA Surg 2017;152:558-64. [PMID: 28273303 DOI: 10.1001/jamasurg.2017.0010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
132 Gaertner WB, Kwaan MR, Madoff RD, Melton GB. Rectal cancer: An evidence-based update for primary care providers. World J Gastroenterol 2015; 21(25): 7659-7671 [PMID: 26167068 DOI: 10.3748/wjg.v21.i25.7659] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
133 Yiqun S, Tong T, Fangqi L, Sanjun C, Chao X, Yajia G, Ye X. Recognition of Anterior Peritoneal Reflections and Their Relationship With Rectal Tumors Using Rectal Magnetic Resonance Imaging. Medicine (Baltimore) 2016;95:e2889. [PMID: 26945377 DOI: 10.1097/MD.0000000000002889] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
134 Wang F, Fan W, Peng J, Lu Z, Pan Z, Li L, Gao Y, Li H, Chen G, Wu X, Ding P, Zeng Z, Wan D. Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial. Cancer Commun (Lond) 2018;38:73. [PMID: 30572939 DOI: 10.1186/s40880-018-0342-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
135 Goldenberg BA, Holliday EB, Helewa RM, Singh H. Rectal Cancer in 2018: A Primer for the Gastroenterologist. Am J Gastroenterol. 2018;. [PMID: 30008472 DOI: 10.1038/s41395-018-0180-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
136 Nakamura T, Sato T, Hayakawa K, Koizumi W, Kumagai Y, Watanabe M. Strategy to avoid local recurrence in patients with locally advanced rectal cancer. Radiat Oncol 2019;14:53. [PMID: 30917848 DOI: 10.1186/s13014-019-1253-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clin Colorectal Cancer 2020;19:116-22. [PMID: 32173279 DOI: 10.1016/j.clcc.2020.02.005] [Reference Citation Analysis]
138 He F, Yu L, Ding Y, Li ZH, Wang J, Zheng J, Chen HY, Liu S, Pang XL, Ajani JA, Wan XB. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.Cancer Sci. 2020;111:4205-4217. [PMID: 32860448 DOI: 10.1111/cas.14636] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
139 McKechnie T, Talwar G, Lee Y, Levine O, Eskicioglu C. Concurrent use of statins and neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2021;36:2715-27. [PMID: 34498133 DOI: 10.1007/s00384-021-04016-3] [Reference Citation Analysis]
140 Koch J, Mönch D, Maaß A, Gromoll C, Hehr T, Leibold T, Schlitt HJ, Dahlke MH, Renner P. Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines. PLoS One 2021;16:e0244513. [PMID: 33395433 DOI: 10.1371/journal.pone.0244513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
141 Angenete E, Langenskiöld M, Falk P, Ivarsson ML. Matrix metalloproteinases in rectal mucosa, tumour and plasma: response after preoperative irradiation. Int J Colorectal Dis 2007;22:667-74. [PMID: 17109104 DOI: 10.1007/s00384-006-0225-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
142 Trakarnsanga A, Ithimakin S, Weiser MR. Treatment of locally advanced rectal cancer: Controversies and questions. World J Gastroenterol 2012; 18(39): 5521-5532 [PMID: 23112544 DOI: 10.3748/wjg.v18.i39.5521] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
143 Greenbaum A, Martin DR, Bocklage T, Lee JH, Ness SA, Rajput A. Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Clin Colorectal Cancer 2019;18:102-9. [PMID: 30935775 DOI: 10.1016/j.clcc.2019.02.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
144 Gaber A, Stene C, Hotakainen K, Nodin B, Palmquist I, Bjartell A, Stenman UH, Jeppsson B, Johnson LB, Jirström K. Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients. Radiat Oncol 2011;6:100. [PMID: 21864386 DOI: 10.1186/1748-717X-6-100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
145 Harada Y, Kazama S, Morikawa T, Sonoda H, Ishi H, Emoto S, Murono K, Kaneko M, Sasaki K, Shuno Y, Nishikawa T, Tanaka T, Kawai K, Hata K, Nozawa H, Ushiku T, Tahara H, Ishihara S. Clinical significance of CD8+ and FoxP3+ tumor-infiltrating lymphocytes and MFG-E8 expression in lower rectal cancer with preoperative chemoradiotherapy. Mol Clin Oncol 2021;14:87. [PMID: 33767856 DOI: 10.3892/mco.2021.2249] [Reference Citation Analysis]
146 Boland PM, Fakih M. The emerging role of neoadjuvant chemotherapy for rectal cancer. J Gastrointest Oncol. 2014;5:362-373. [PMID: 25276409 DOI: 10.3978/j.issn.2078-6891.2014.060] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
147 Huang WS, Kuan FC, Lin MH, Chen MF, Chen WC. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer. Ann Surg Oncol 2020;27:4309-18. [PMID: 32794029 DOI: 10.1245/s10434-020-09018-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Sautter-Bihl ML, Hohenberger W, Fietkau R, Rödel C, Schmidberger H, Sauer R. Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it? Strahlenther Onkol 2013;189:105-10. [PMID: 23299826 DOI: 10.1007/s00066-012-0299-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
149 Nakamura T, Watanabe M. Lateral lymph node dissection for lower rectal cancer. World J Surg. 2013;37:1808-1813. [PMID: 23703637 DOI: 10.1007/s00268-013-2072-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
150 Resende Salgado L, Hsu H, Du K. Outcomes of rectal cancer with liver oligometastases. J Gastrointest Oncol 2014;5:414-20. [PMID: 25436119 DOI: 10.3978/j.issn.2078-6891.2014.078] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
151 Veenhof AA, Kropman RH, Engel AF, Craanen ME, Meijer S, Meijer OW, van der Peet DL, Cuesta MA. Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery. Int J Colorectal Dis. 2007;22:507-513. [PMID: 17009009 DOI: 10.1007/s00384-006-0195-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
152 Ahmed S, Eng C. Neoadjuvant Strategies: Locally Advanced Rectal Cancer. Clin Colon Rectal Surg. 2017;30:383-386. [PMID: 29184474 DOI: 10.1055/s-0037-1606372] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
153 Dagoglu N, Nedea E, Poylin V, Nagle D, Mahadevan A. Post operative stereotactic radiosurgery for positive or close margins after preoperative chemoradiation and surgery for rectal cancer. J Gastrointest Oncol 2016;7:315-20. [PMID: 27284461 DOI: 10.21037/jgo.2015.11.03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
154 Aklilu M, Eng C. The current landscape of locally advanced rectal cancer. Nat Rev Clin Oncol. 2011;8:649-659. [PMID: 21826084 DOI: 10.1038/nrclinonc.2011.118] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
155 Spatola C, Privitera G, Milazzotto R, Tocco A, Acquaviva G, Marletta F, Marino L, Di Grazia A, Salvo R, Cartia G, Platania A, Molino L, Santacaterina A, Mattace Raso M, Frosina P, Ianni R, Bono M, Liardo L, Bonanno S, La Paglia L, Federico M, Fazio I, Mortellaro G, Ferrera G, Tripoli A, Evangelista G, Daidone A, Biti G, Badalamenti M, Ognibene L, Cacciola A, Parisi S, Pergolizzi S. Trends in combined radio-chemotherapy for locally advanced rectal cancer: a survey among radiation oncology centers of Sicily region on behalf of AIRO. Radiol Med 2019;124:671-81. [PMID: 30806918 DOI: 10.1007/s11547-019-01007-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
156 Ho V, Chung L, Singh A, Lea V, Abubakar A, Lim SH, Ng W, Lee M, de Souza P, Shin JS, Lee CS. Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis. BMC Cancer 2018;18:869. [PMID: 30176843 DOI: 10.1186/s12885-018-4776-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
157 Serra-Rexach JA, Jimenez AB, García-Alhambra MA, Pla R, Vidán M, Rodríguez P, Ortiz J, García-Alfonso P, Martín M. Differences in the therapeutic approach to colorectal cancer in young and elderly patients. Oncologist. 2012;17:1277-1285. [PMID: 22923453 DOI: 10.1634/theoncologist.2012-0060] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
158 Narayanan S, Attwood K, Gabriel E, Nurkin S. Pathologic Complete Response Despite Nodal Yield Has Best Survival in Locally Advanced Rectal Cancer. J Surg Res 2020;251:220-7. [PMID: 32172008 DOI: 10.1016/j.jss.2020.01.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
159 Uda S, Mukai M, Kishima K, Yokoyama D, Hasegawa S, Koike T, Tajima T, Nomura E, Tomita K, Matsumoto T, Hasebe T, Makuuchi H. Pelvic local recurrence as first relapse predicts prognosis for clinical stage II/III lower rectal cancer: A clinicopathological investigation. Mol Clin Oncol 2021;14:33. [PMID: 33414914 DOI: 10.3892/mco.2020.2195] [Reference Citation Analysis]
160 Räsänen M, Renkonen-Sinisalo L, Mustonen H, Lepistö A. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study. World J Surg Oncol 2019;17:139. [PMID: 31395058 DOI: 10.1186/s12957-019-1670-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
161 Liu SL, O'Brien P, Zhao Y, Hopman WM, Lamond N, Ramjeesingh R. Adjuvant treatment in older patients with rectal cancer: a population-based review. Curr Oncol 2018;25:e499-506. [PMID: 30607116 DOI: 10.3747/co.25.4102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
162 Lee EM, Hong YS, Kim KP, Lee JL, Kim SY, Park YS, Choi DH, Kim JH, Lim SB, Yu CS, Kim JC, Lee JH, Kim AY, Kim TW. Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer. Cancer Sci 2013;104:111-5. [PMID: 23057495 DOI: 10.1111/cas.12041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
163 Pach R, Richter P, Sierzega M, Papp N, Szczepanik A. Preoperative Short-Course Radiotherapy and Surgery versus Surgery Alone for Patients with Rectal Cancer: A Propensity Score-Matched Analysis at 18-Year Follow-Up. Biomedicines 2021;9:725. [PMID: 34202691 DOI: 10.3390/biomedicines9070725] [Reference Citation Analysis]
164 Uehara K, Nagino M. Neoadjuvant treatment for locally advanced rectal cancer: a systematic review. Surg Today 2016;46:161-8. [PMID: 26170102 DOI: 10.1007/s00595-015-1218-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
165 Hathout L, Williams TM, Jabbour SK. The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes In Rectal Cancer. Curr Colorectal Cancer Rep 2017;13:61-72. [PMID: 29445322 DOI: 10.1007/s11888-017-0351-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
166 Hartvigson PE, Apisarnthanarax S, Schaub S, Cohen S, Bernier G, Koh WJ, Kim EY. Radiation Therapy Dose Escalation to Clinically Involved Pelvic Sidewall Lymph Nodes in Locally Advanced Rectal Cancer. Adv Radiat Oncol 2019;4:478-86. [PMID: 31360803 DOI: 10.1016/j.adro.2019.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
167 Wahba HA, El-Hadaad HA, Roshdy S. Combination of irinotecan and 5-fluorouracil with radiation in locally advanced rectal adenocarcinoma. J Gastrointest Cancer 2012;43:467-71. [PMID: 22147447 DOI: 10.1007/s12029-011-9350-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]